Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Enhanced antitumor activity of a novel, oral, helper epitope-containing WT1 protein vaccine in a model of murine leukemia

Fig. 2

A Time-course changes in WT1-specific CTL frequency in CD8+ T cells in PB. WT1, Wilms’ tumor 1; CTL, cytotoxic T lymphocyte; PB, peripheral blood. Values are expressed as mean ± SE. *: p < 0.05; **: p < 0.01. B Correlations between WT1-specific CTL frequency in CD8+ T cells in PB and tumor volume on day 20 after subcutaneous inoculation to mice in the B. longum 420 and B. longum 420/2656 combination groups. WT1, Wilms’ tumor 1; CTL, cytotoxic T lymphocyte; PB, peripheral blood

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us